Lista de obras - F Bosch - Dominio Público Uruguay

A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.

artículo científico publicado en 2015

A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia

artículo científico publicado en 2016

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

artículo científico publicado en 2015

A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia

artículo científico publicado en 2015

ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances

artículo científico publicado en 2002

Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia

artículo científico publicado en 2007

Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes

artículo científico publicado en 2004

Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica

artículo científico publicado en 2017

Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of UnmutatedVHGene in Patients With Chronic Lymphocytic Leukemia

article published in 2005

Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide

artículo científico publicado en 2004

Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis

artículo científico publicado en 2014

Beyond hemostasis: the challenge of treating plasminogen deficiency. A report of three cases

Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion

article

Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients

artículo científico publicado en 1996

Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative

scientific article published on 06 January 2021

CDK4andMDM2Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-typeINK4a/ARFLocus

article

Central nervous system involvement in mantle cell lymphoma

artículo científico publicado en 2007

Chronic lymphocytic leukaemia: from genetics to treatment

scientific article published on 01 November 2019

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2003

Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia

artículo científico publicado en 2006

Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia

artículo científico publicado en 2006

Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era.

artículo científico publicado en 2010

Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell T

article

Cutaneous lymphocyte-associated antigen (CLA) expression in a lymphoblastoid mantle cell lymphoma presenting with skin lesions. Comparison with other clinicopathologic presentations of mantle cell lymphoma.

artículo científico publicado en 2001

Differential gene expression profile associated to apoptosis induced by dexamethasone in CLL cells according to IGHV/ZAP-70 status

artículo científico publicado en 2012

Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin

artículo científico publicado en 2005

Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect

artículo científico publicado en 2016

Erratum: Corrigendum: Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

scholarly article published in Nature Medicine

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

artículo científico publicado en 2010

Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient

article

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

scientific article published on 11 July 2020

Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia

artículo científico publicado en 2011

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

artículo científico publicado en 2020

Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue

artículo científico publicado en 2008

Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia

artículo científico publicado en 2002

Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication

artículo científico publicado en 2008

Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients

artículo científico publicado en 2006

Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia

article

Gene expression profiling in chronic lymphocytic leukaemia

scientific article published on June 2009

Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia

artículo científico publicado en 2008

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

article

Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution

artículo científico publicado en 1998

How I treat refractory CLL.

artículo científico publicado en 2005

Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease

artículo científico publicado en 2000

Ibrutinib in CLL: 2 sides of the same coin

artículo científico publicado en 2015

Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms

artículo científico publicado en 2005

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia

artículo científico publicado en 2021

Importance of hepatitis B virus screening in hematological patients

artículo científico publicado en 2015

Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience

artículo científico publicado en 2009

Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma

artículo científico publicado en 2003

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment

artículo científico publicado en 2008

Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells

artículo científico publicado en 2016

Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance

artículo científico publicado en 2002

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

artículo científico publicado en 2016

Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy

artículo científico publicado en 2006

Leukemic involvement is a common feature in mantle cell lymphoma

artículo científico publicado en 2007

Limitations of Gallium-67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome

scientific article published on 01 November 2002

Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution.

artículo científico publicado en 1994

Malignant transformation in IgM monoclonal gammopathy of undetermined significance

article published in 2003

Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors

artículo científico publicado en 1998

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.

artículo científico publicado en 2012

Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2001

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

scientific article published on 27 August 2019

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations

artículo científico publicado en 2006

Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

artículo científico publicado en 1998

Personalizing treatment for chronic lymphocytic leukemia

artículo científico publicado en 2011

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-cell Lymphoma

artículo científico publicado en 2020

Polycythaemia Vera Following Non-Hodgkin's Lymphoma

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy

scientific article published on 11 May 2020

Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression.

artículo científico publicado en 2004

Primary gastrointestinal aspergillosis 6 months after allogeneic hematopoietic cell transplantation: a case report.

artículo científico publicado en 2013

Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.

artículo científico publicado en 1994

Renal Failure in Multiple Myeloma

artículo científico publicado en 1998

Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation

artículo científico publicado en 2009

Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors

artículo científico publicado en 2010

Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?

artículo científico publicado en 2002

Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2002

Survival after progression in patients with follicular lymphoma: analysis of prognostic factors

artículo científico publicado en 2002

Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein.

artículo científico publicado en 2014

The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.

artículo científico publicado en 2006

The IV International Chronic Lymphocytic Leukemia Young Investigators' Meeting

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity

artículo científico publicado en 2002

ZAP-70 Expression in Normal Pro/Pre B Cells, Mature B Cells, and in B-Cell Acute Lymphoblastic Leukemia

artículo científico publicado en 2006

ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation

artículo científico publicado en 2011

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

artículo científico publicado en 2003

ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation

artículo científico publicado en 2013

Lista de obras de F Bosch

A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.

A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic Leukemia

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia

ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances

Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia

Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes

Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica

Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of UnmutatedVHGene in Patients With Chronic Lymphocytic Leukemia

Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide

Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis

Beyond hemostasis: the challenge of treating plasminogen deficiency. A report of three cases

Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion

Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients

Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative

CDK4andMDM2Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-typeINK4a/ARFLocus

Central nervous system involvement in mantle cell lymphoma

Chronic lymphocytic leukaemia: from genetics to treatment

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia

Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia

Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era.

Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell T

Cutaneous lymphocyte-associated antigen (CLA) expression in a lymphoblastoid mantle cell lymphoma presenting with skin lesions. Comparison with other clinicopathologic presentations of mantle cell lymphoma.

Differential gene expression profile associated to apoptosis induced by dexamethasone in CLL cells according to IGHV/ZAP-70 status

Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin

Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect

Erratum: Corrigendum: Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue

Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia

Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication

Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients

Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia

Gene expression profiling in chronic lymphocytic leukaemia

Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution

How I treat refractory CLL.

Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease

Ibrutinib in CLL: 2 sides of the same coin

Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia

Importance of hepatitis B virus screening in hematological patients

Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience

Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment

Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells

Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy

Leukemic involvement is a common feature in mantle cell lymphoma

Limitations of Gallium-67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome

Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution.

Malignant transformation in IgM monoclonal gammopathy of undetermined significance

Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.

Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations

Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

Personalizing treatment for chronic lymphocytic leukemia

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-cell Lymphoma

Polycythaemia Vera Following Non-Hodgkin's Lymphoma

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy

Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression.

Primary gastrointestinal aspergillosis 6 months after allogeneic hematopoietic cell transplantation: a case report.

Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.

Renal Failure in Multiple Myeloma

Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation

Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors

Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?

Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia

Survival after progression in patients with follicular lymphoma: analysis of prognostic factors

Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein.